IBD Stock News for
Emagin Corporation (EMAN): Earnings Report Focus Fundamental Emagin Corporation will report quarterly earnings on May 13. Emagin Corporation has an Earnings Per Share Rating of 72 from IBD, meaning that recent earnings growth has outperformed 72% of all stocks in IBD's database. In its latest quarter, profit grew 40%. In the last three quarters, profit growth has averaged 61%. In its latest quarter, sales grew 18% to $7.96 million. Focus on stocks showing strong quarterly earnings growth in recent quarters, at least 25% or more. IBD studies of past market winners showed big earnings and sales growth in recent quarters before big price moves. Emagin Corporation's annual profit margin is 26.3%. That means the company is generating 26.3 cents in profit for each $1 in sales. TechnicalEmagin Corporation is 8.92% off its 52-week high. In the past four weeks, Emagin Corporation is up 15.06%. Year-to-date, it's up 20.63%. IBD research has consistently shown that stocks showing strong relative price performance in the market have the best chance of being market leaders. Rather than try to catch stocks on sale, target the leading price performers in the market. Emagin Corporation has an Up/Down volume ratio of 1.4 which indicates that volume on up days is exceeding volume on down days. A ratio above 1.0 implies positive demand for shares. Emagin Corporation's volume % change is 54.6%. That means volume is on pace to be 54.6% above average. A stock's volume percent change can tell you if institutional investors are fueling a stock's gain or decline. Big volume always gives them away. Big investors like mutual funds, banks and insurance companies account for about 75% of the trading volume each day on the exchanges so it's important to pay attention to what they're buying and selling. Emagin Corporation's stock price is $8.48 and it has a 50-day average volume of 267,100 shares. It's generally best to focus on higher-priced, liquid names rather than low-priced, illiquid ones. Mutual funds and other big investors rarely look at stocks priced under $10 that are thinly traded. Institutional investors generally prefer liquid names so they can buy and sell easily. The best time to buy stocks is when the major stock indexes are in an uptrend. Target your buys to firms showing strong earnings and sales growth in recent quarters thanks to an innovative new product or service. Stocks like this will generally be trading closer to new high ground. In the early stages of a new rally, stocks staging technical breakouts in heavy volume from sound bases have a good chance of becoming market leaders. Sometimes, a market rally will come under pressure when there are increasing signs of institutional selling in the market. Institutional selling is seen by a rising number of distribution days, or heavier-volume declines, by the major stock indexes. Selling like this can stop a market rally in its tracks. When the outlook turns to market rally under pressure, it's time to assess stocks in your portfolio and consider locking in partial or full profits. And if you have a small loss in a stock, consider selling to minimize losses. Cash is a good place to be when the major stock indexes are in a correction. Market corrections occur due to heavy institutional selling in the market. Distribution days, or heavier-volume declines, in the indexes are generally a sign of institutional selling. When the market tide is flowing negative, it's a risky environment for new buys. http://www.investors.com/StockResearch/StockNews/...oration-EMAN.aspx |
Thread abonnieren
